Abstract

Endometrial cancers originate from epithelial cells lining the uterus and account for ~76,000 deaths annually among women worldwide. Histopathological subtypes of endometrial cancer include endometrioid and serous carcinomas, as well as carcinosarcomas. Recent whole exome sequencing of these three subtypes, including an integrated genomic analysis of endometrioid and serous endometrial cancers by The Cancer Genome Atlas, has uncovered both distinguishing and shared molecular features within their genomic landscapes. Consequently, we now understand that endometrioid and serous endometrial cancers can be classified into four distinct molecular subgroups: POLE (ultramutated), microsatellite instability (hypermutated), copy number low (microsatellite stable), and copy number high (serous-like). In this chapter, we review the current state of knowledge of endometrial cancer genomics, both in the context of histopathological subtypes and their underlying molecular subgroups, with an emphasis on the genes and pathways that are frequently perturbed.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.